(RMS) Hermes International SCA - Overview
Stock: Leather Goods, Ready-To-Wear, Accessories, Silk, Perfume
| Risk 5d forecast | |
|---|---|
| Volatility | 25.5% |
| Relative Tail Risk | -6.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.95 |
| Alpha | -34.04 |
| Character TTM | |
|---|---|
| Beta | 0.902 |
| Beta Downside | 1.124 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.74% |
| CAGR/Max DD | 0.25 |
Description: RMS Hermes International SCA January 26, 2026
Hermès International SCA (ticker RMS) is a French luxury conglomerate that designs, manufactures, and sells a broad portfolio of high-end products, ranging from leather goods, ready-to-wear, accessories, silk textiles, and perfume to watches and tableware. Its value chain includes vertically integrated activities such as tanning, weaving, engraving, and metal-part production, and it distributes primarily through its own network of boutiques across Europe, Asia-Pacific, the Americas, and the Middle East.
Key recent metrics (FY 2023, disclosed 28 Feb 2024): revenue €12.6 bn (+13 % YoY), operating margin 30.8 % (up from 27.5 % in 2022), and net profit €4.0 bn, reflecting strong demand in Asia-Pacific (+18 % YoY) and resilient performance in the United States despite a 3 % slowdown in discretionary spending. The luxury sector’s global growth rate is projected at 5-6 % CAGR through 2028, driven by rising affluent consumer bases in China and India, while the European luxury market remains a modest 1-2 % growth environment (McKinsey 2023). Hermès’ same-store sales in China grew 22 % YoY, a key driver of its overall earnings expansion.
Given the company’s high operating leverage and consistent cash-generation, a quantitative deep-dive-such as a discounted cash-flow or comparable-company analysis-can help gauge whether the current market price fully reflects its growth runway; you might start that exploration on ValueRay for up-to-date valuation multiples and scenario modeling.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 6.76b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.39 > 0.02 and ΔFCF/TA 24.07 > 1.0 |
| NWC/Revenue: 53.76% < 20% (prev 48.66%; Δ 5.10% < -1%) |
| CFO/TA 0.44 > 3% & CFO 10.59b > Net Income 6.76b |
| Net Debt (-7.91b) to EBITDA (11.98b): -0.66 < 3 |
| Current Ratio: 4.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (105.0m) vs 12m ago 0.12% < -2% |
| Gross Margin: 69.23% > 18% (prev 0.70%; Δ 6853 % > 0.5%) |
| Asset Turnover: 105.6% > 50% (prev 102.1%; Δ 3.52% > 0%) |
| Interest Coverage Ratio: 185.1 > 6 (EBITDA TTM 11.98b / Interest Expense TTM 56.0m) |
Altman Z'' 8.09
| A: 0.52 (Total Current Assets 15.91b - Total Current Liabilities 3.19b) / Total Assets 24.32b |
| B: 0.19 (Retained Earnings 4.52b / Total Assets 24.32b) |
| C: 0.46 (EBIT TTM 10.37b / Avg Total Assets 22.41b) |
| D: 0.90 (Book Value of Equity 4.94b / Total Liabilities 5.47b) |
| Altman-Z'' Score: 8.09 = AAA |
Beneish M -2.84
| DSRI: 1.38 (Receivables 833.0m/535.0m, Revenue 23.67b/20.93b) |
| GMI: 1.01 (GM 69.23% / 70.21%) |
| AQI: 0.89 (AQ_t 0.12 / AQ_t-1 0.14) |
| SGI: 1.13 (Revenue 23.67b / 20.93b) |
| TATA: -0.16 (NI 6.76b - CFO 10.59b) / TA 24.32b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of RMS shares?
Over the past week, the price has changed by +1.93%, over one month by -0.66%, over three months by +0.33% and over the past year by -20.69%.
Is RMS a buy, sell or hold?
What are the forecasts/targets for the RMS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2370.2 | 12.5% |
| Analysts Target Price | - | - |
RMS Fundamental Data Overview February 24, 2026
P/E Trailing = 48.0046
P/E Forward = 43.4783
P/S = 13.555
P/B = 11.5731
P/EG = 4.5451
Revenue TTM = 23.67b EUR
EBIT TTM = 10.37b EUR
EBITDA TTM = 11.98b EUR
Long Term Debt = 34.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 650.0m EUR (from shortTermDebt, last quarter)
Debt = 4.33b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -7.91b EUR (from netDebt column, last quarter)
Enterprise Value = 209.00b EUR (216.91b + Debt 4.33b - CCE 12.24b)
Interest Coverage Ratio = 185.1 (Ebit TTM 10.37b / Interest Expense TTM 56.0m)
EV/FCF = 22.17x (Enterprise Value 209.00b / FCF TTM 9.43b)
FCF Yield = 4.51% (FCF TTM 9.43b / Enterprise Value 209.00b)
FCF Margin = 39.83% (FCF TTM 9.43b / Revenue TTM 23.67b)
Net Margin = 28.55% (Net Income TTM 6.76b / Revenue TTM 23.67b)
Gross Margin = 69.23% ((Revenue TTM 23.67b - Cost of Revenue TTM 7.28b) / Revenue TTM)
Gross Margin QoQ = 71.55% (prev 66.27%)
Tobins Q-Ratio = 8.59 (Enterprise Value 209.00b / Total Assets 24.32b)
Interest Expense / Debt = 0.60% (Interest Expense 26.0m / Debt 4.33b)
Taxrate = 31.11% (1.03b / 3.32b)
NOPAT = 7.14b (EBIT 10.37b * (1 - 31.11%))
Current Ratio = 4.99 (Total Current Assets 15.91b / Total Current Liabilities 3.19b)
Debt / Equity = 0.23 (Debt 4.33b / totalStockholderEquity, last quarter 18.84b)
Debt / EBITDA = -0.66 (Net Debt -7.91b / EBITDA 11.98b)
Debt / FCF = -0.84 (Net Debt -7.91b / FCF TTM 9.43b)
Total Stockholder Equity = 16.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 30.15% (Net Income 6.76b / Total Assets 24.32b)
RoE = 39.86% (Net Income TTM 6.76b / Total Stockholder Equity 16.96b)
RoCE = 61.02% (EBIT 10.37b / Capital Employed (Equity 16.96b + L.T.Debt 34.0m))
RoIC = 40.51% (NOPAT 7.14b / Invested Capital 17.63b)
WACC = 7.01% (E(216.91b)/V(221.24b) * Re(7.14%) + D(4.33b)/V(221.24b) * Rd(0.60%) * (1-Tc(0.31)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF Debug] Terminal Value 84.56% ; FCFF base≈6.86b ; Y1≈8.46b ; Y5≈14.41b
Fair Price DCF = 2978 (EV 304.29b - Net Debt -7.91b = Equity 312.20b / Shares 104.8m; r=7.01% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 3.56 | EPS CAGR: -52.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: 97.70 | Revenue CAGR: 32.43% | SUE: 0.01 | # QB: 0
EPS current Year (2026-12-31): EPS=46.81 | Chg30d=-0.764 | Revisions Net=-7 | Growth EPS=+8.7% | Growth Revenue=+8.2%
EPS next Year (2027-12-31): EPS=53.50 | Chg30d=+0.116 | Revisions Net=+4 | Growth EPS=+14.3% | Growth Revenue=+9.1%